Insights

Here’s why the Medibank (ASX:MPL) share price is up 12% in the last 3 months

A premium relief policy announced in June has garnered positive sentiment towards the health insurer.
The post Here’s why the Medibank (ASX:MPL) share price is up 12% in the last 3 months appeared first on The Motley Fool Australia. –

The Medibank Private Ltd (ASX: MPL) share price has had a stellar run recently.

In the last 3 months, shares in the health insurer have rallied nearly 12%.

Let’s take a look at what’s been fuelling the Medibank share price.

Why is the Medibank share price booming?

There have been several catalysts that have helped propel the Medibank share price higher since June.

Working back, the initial push came from the health insurer’s premium relief payments policy.

On 29 June, the company announced that it will return approximately $105 million to customers impacted by the COVID-19 pandemic through premium relief payments.

Medibank noted that the premium relief program would cover approximately 2 million accounts.

Positive outlook notes from various brokers and funds also help improve sentiment towards the health insurer.

The Medibank share price received an additional boost in late August after releasing its full-year report.

How did Medibank perform in FY21?

Medibank released a promising full-year report for FY21, fuelled by consumers prioritising their health and wellbeing.

The company’s report was headlined by a 40% increase in net profit after tax (NPAT) of $441 million.

Other highlights from Medibank’s full-year report included:

Revenue increase of 1.99% on the prior corresponding period (pcp) to $6.9 billion
4,900% increase in net investment income of $120 million

Earnings per share (EPS) of 16 cents – up 39.8% on the pcp
A full-year dividend payout of 12.7 cents per share

Medibank is forecasting a 2.4% growth in underlying average net claims in FY22.

The company also has a $15 million target for productivity savings and is targeting a heavier focus on inorganic growth for FY22.

Snapshot of the Medibank share price

In addition to a solid past 3 months, shares in Medibank have also had a stellar year thus far.

Since the start of 2021, shares in the health insurer have soared more than 17% higher.

By comparison, the broader S&P/ASX200 Index (ASX: XJO) has only managed to climb 11% higher for the year.

The Medibank share price closed yesterday’s session slightly higher at $3.55.

The post Here’s why the Medibank (ASX:MPL) share price is up 12% in the last 3 months appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank Private right now?

Before you consider Medibank Private, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

An ASX correction could be coming: Here’s what to do

5 things to watch on the ASX 200 on Friday

Why the embattled AGL (ASX:AGL) share price is surging higher today
These 3 ASX 200 shares are topping trading volumes today

APA Group (ASX:APA) share price jumps on strong support for its takeover bid

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!